部分脾栓塞术的临床应用  

Clinical application of partial splenic embolization

作　　者：宁志方[1] 陶智慧[1] 马勇[1] 

机构地区：[1]哈尔滨242医院,150066

出　　处：《哈尔滨医药》2006年第3期2-4,共3页Harbin Medical Journal

摘　　要：目的探讨部分脾栓塞术(PSE)的临床应用。方法采用PSE治疗肝癌伴脾亢(HCC-HS)86例,其它继发性脾亢(SHS)26例,原发性血小板减少性紫癜(ITP)5例,其中20例2次以上PSE。结果平均栓塞范围HCC-HS组为36%,SHS组为60%,ITP组为74%;临床有效率分别为84.8%、88.5%、100%。HCC-HS组因单次栓塞范围较小,约20.9%(18/86)病人需行再次栓塞。全部病例均未发生严重并发症。结论PSE是安全有效的,可作为外科脾切除的替代疗法。HCC-HS组为了减轻术后并发症PSE可分次进行。Objective：To probe the chinical application of partial splenic embolization （PSE）. Methods：86 cases of hepatocellular carcionma with hypersplenism （HCC-HS）, 26 cases of secondary hypersplenism（SHS） and 5 cases of idiopathic thrombocytopenic purpura（ITP）have been treated by PSE. Results ：The average extents of HCC-HS,SHS and ITP emboliztion were 36% ,60% ,74% respectively,and the clinical effective rates were 84.8 %, 88.5 %, 100% respectively,and the clinical effective rates were 84. 8% ,88.5% ,100% respectively. Because of the extent of once embolization was too small in the HCC-HS group ,20.9%（18/86） patients had to he treated again by PSE. No severe complication occurred in all cases. Conclusion：PSE is a safe and effective therapy,and it could take the place of surgical splenecomy under certain condition as indicated. To decrease complication of postoperative HCC-HS patients, the PSE should he carried out twice or more.

关 键 词：部分脾栓塞术 脾功能亢进 原发性血小板紫癜 

分 类 号：R445[医药卫生—影像医学与核医学]